Nova Peptides Review: Pricing, COAs, Testing, and What We Found
An independent Nova Peptides review covering openly priced research vials, GLP-1 SM / GLP-2 TZ / GLP-3 RT / SUPER-31 house labels, and the public /coas/ archive on novapeptidesupply.com — distinct from Nova Life Peptides and NovaPeptide.us.
Nova Peptides (novapeptidesupply.com) is now a curated vendor on PeptideBenchmark. That decision rests on what a reader can check without guessing — public prices, milligram strengths, house-label mappings, and a centralized /coas/ archive whose Freedom Diagnostics lots can be confirmed at the laboratory.
Reviewed September 16, 2026; certificate coverage re-audited September 18, 2026. PeptideBenchmark has no affiliate, coupon, sponsorship, or paid-placement relationship with Nova Peptides. The vendor sells research-use-only products; this is a commercial-transparency and documentary-evidence review, not human-use guidance or medical advice. This storefront is not Nova Life Peptides and not NovaPeptide.us.
The short version
We found a research storefront with:
- openly priced single-vial offers and Size variations on the public catalog;
- house labels GLP-1 SM, GLP-2 TZ, GLP-3 RT, and SUPER-31 for semaglutide, tirzepatide, retatrutide, and SS-31;
- U.S.-made / U.S. overnight shipping language (no street-level address verified);
- a public /coas/ archive that advertises 41 products and 164 certificates, with downloadable PDFs on the storefront.
The catalog is usable for $/mg comparison without an account. Certificates are centralized on /coas/ rather than living only as scattered product-gallery images. PeptideBenchmark confirms Freedom Diagnostics search codes independently when they resolve under Nova Peptides; a matched report documents the tested sample and does not endorse every vial. Ethos Analytics and previous-supplier files stay vendor-hosted.
What we found in the catalog
Nova Peptides lists live prices on its public catalog. PeptideBenchmark promotes every clean mg-normalized vial so Pricing and Stack Builder stay honest.
| Catalog result | Count | PB treatment |
|---|---|---|
| Public parent / variation offers audited | 63 | Kept in the catalog check |
| Comparable in-stock vial rows | 40 | Published to Pricing and Stack Builder |
| Out of stock | 0 | — |
| Deferred from the vial lane at review time | 16 | Sprays, capsules, 1 mg SLU-PP-332 dry-fill units, hCG IU |
| Out of scope | 7 | BAC water, acetic acid, shipping insurance, Enclomiphene, Amino Tadalafil, RU/Minoxidil, Noopept |
Rows deferred from the vial board at review time, with their original reasons and treatment in the September 18, 2026 unified-pricing snapshot:
- DSIP Spray 10MG, Semax / Selank sprays, NAD+ sprays, PT-141 spray, MT-2 spray, Selank sprays, Semax sprays — 9 qualifying Nova offers appear in Ready sprays
- KPV Capsules 500 mcg, 5-Amino-1MQ Capsules 50 mg, BPC-157 500 mcg dry-fill — 1 qualifying Nova dry-fill offer appears in Capsules; the others remain deferred
- SLU-PP-332 — storefront copy describes 1 mg dry-fill research units, not a comparable lyophilized vial
- HCG 5000 IU — now compared in the IU hormones tab and never converted to milligrams
These format tabs preserve the original rule: sprays, capsule/dry-fill products, and IU-dosed hormones are not mixed into the vial $/mg ranking.
House labels matter here:
- GLP-1 SM → semaglutide
- GLP-2 TZ → tirzepatide
- GLP-3 RT → retatrutide
- SUPER-31 → SS-31
KLOW is the labeled 80 mg four-peptide vial; GLOW is the labeled 70 mg three-peptide vial. The CJC-1295 No DAC / Ipamorelin listing is a 5 mg + 5 mg blend (10 mg total).
Current offers can be compared on PeptideBenchmark Pricing, and mixed-product requirements can be modeled in the Stack Builder.
Testing transparency
Browse preserved records in the Nova Peptides COA results.
The public /coas/ page advertises 41 products and 164 certificates. PeptideBenchmark reviewed 184 downloadable PDFs from that archive and the storefront’s public certificate uploads — later pages of the certificate library were missing from the first onboarding pass. 125 Freedom Diagnostics documents two-factor verified — the vendor PDF’s Nova* search code resolved at the laboratory under client Nova Peptides. 32 Ethos Analytics reports and 15 Vanguard Laboratory files remain vendor-hosted: Ethos has no public lookup PeptideBenchmark can confirm, and the Vanguard reports do not resolve through a public laboratory search where a wrong code fails. Twelve Freedom-looking files stay vendor-hosted because the laboratory object 404s or the provider lot does not match the vendor copy.
Two Freedom lots in the public record (2606120543 and 2607080125) report no analyte detected at 0.00%. Those measured zeros remain in the archive; they are not missing-value sentinels, and they keep PeptideBenchmark from treating Nova’s purity average as uniformly high-quality.
A matched laboratory report documents the tested sample. HPLC lots at or above 90% in this review averaged 99.5% reported purity. That is not a sterility guarantee for every vial that later ships under the same label.
Nova’s currently published NAD spray PDFs are Ethos lots NV-S-A7K3 (1000 mg, sample 26EA0505-049) and NV-S-H9L4 (1500 mg, sample 26EA0618-038), customer Nova Research. Neither is the February Glow Aminos / Flawless Compounds sample 26EA0216-021. Writeup: NAD+ spray COA: Glow Aminos and Flawless Compounds share one Ethos analysis.
Location and fulfillment claims
Public storefront copy states U.S.-made peptides and U.S. overnight shipping, with support at [email protected]. PeptideBenchmark maps only that country-level operating signal on the peptide map until a city or street-level address is published.
What this review does not claim
- No binary “safe / unsafe” or “legitimate / illegitimate” verdict
- No endorsement of human use
- No claim that every SKU has a currently resolvable laboratory report
- No affiliate, coupon, or sponsorship relationship at the time of review
- No identity overlap with Nova Life Peptides or NovaPeptide.us
Live profile
Follow the living evidence on the Nova Peptides vendor profile, including pricing rows, trust metrics, and links into the COA database. Scoring methodology is documented on How we score vendors.
Common questions
Is Nova Peptides legitimate?
PeptideBenchmark does not issue binary legitimacy or product-safety endorsements. We confirmed an openly priced research catalog on novapeptidesupply.com, U.S. fulfillment language, and a public /coas/ archive with Freedom Diagnostics certificates that resolve under the Nova Peptides client name where lookup succeeds. Those facts create an inspectable commercial and documentary record; they do not establish the condition or safety of a physical vial.
Does Nova Peptides publish COAs?
Yes. The public /coas/ archive advertises certificates across the catalog, and matching PDFs are downloadable from the storefront. PeptideBenchmark confirmed 125 Freedom Diagnostics documents at the laboratory under client Nova Peptides. Additional Ethos Analytics and Vanguard files remain vendor-hosted because they do not resolve at a public laboratory lookup PeptideBenchmark can confirm.
What do GLP-1 SM, GLP-2 TZ, GLP-3 RT, and SUPER-31 mean?
They are Nova Peptides storefront labels. PeptideBenchmark maps GLP-1 SM to semaglutide, GLP-2 TZ to tirzepatide, GLP-3 RT to retatrutide, and SUPER-31 to SS-31 for cross-vendor comparison.
Is this the same company as Nova Life Peptides or NovaPeptide.us?
No. Nova Peptides on novapeptidesupply.com is a distinct storefront from Nova Life Peptides (novalifepeptides.com) and from NovaPeptide (novapeptide.us). PeptideBenchmark tracks them separately.
Where is Nova Peptides based?
Public storefront copy states U.S.-made peptides and U.S. overnight shipping, with support at [email protected]. PeptideBenchmark did not find a street-level public address on the reviewed pages and maps only that country-level operating signal.
Does PeptideBenchmark have an affiliate relationship with Nova Peptides?
No. At the time of this review, PeptideBenchmark had no affiliate, coupon, sponsorship, or paid-placement relationship with Nova Peptides.